Funding support for 'living guidelines' on COVID-19 management


To support guidance for clinicians, the National COVID-19 Clinical Evidence Taskforce, which includes a large coalition of peak health professional bodies will receive $1.5 million from the Medical Research Future Fund (MRFF) to ensure they are given the best possible advice on managing COVID-19 patients.


The Taskforce has been convened by the Australian Living Evidence Consortium, led by Cochrane Australia based in the School of Public Health and Preventive Medicine, Monash University. To provide front-line health care workers with the most up-to-date information and advice on the disease in a rapidly evolving environment. They will:

  • Analyse emerging national and international research and data on COVID-19.

  • Their recommendations will be continually reviewed and updated in near ‘real-time’.


The initial set of recommendations will be launched and will address priority topics in urgent need of clear and unified guidance, including:

  • Drug treatment of COVID-19 infection

  • Use of oxygen therapies

  • Key elements of critical care, and

  • Disease categories and monitoring.


Additional topics and recommendations for special populations will be added in the coming weeks.


This latest investment is in addition to the Government’s $2.4 billion corona virus National Health Plan that is providing support across primary care, aged care, hospitals, research and the National Medical Stockpile.


MORE INFORMATION:

For the latest advice, information and resources, go to https://www.health.gov.au/

Feel free to contact us at office@gordondu-associates.com.au or (08) 9345 0499.


#gordonqcduandassociates #gordondu # #coronavirus #advice #livingguidelines #topics #funding #support #stayathome

  • Facebook
  • Twitter

© Copyright 2022 Gordon Q C Du & Associates Pty Ltd  | All Rights Reserved